Clamp-down on drug compounders eyed by ex-HHS chief

06/20/2013 | Hill, The

The creation of the Working Group on Pharmaceutical Safety was announced Wednesday by former HHS Secretary Tommy Thompson to push for tighter oversight of drug compounders. The group is pushing for a ban on the compounding of medicines that are basically copies of already available drugs, as well as greater restrictions on medicines that fail to pass federal safety standards and drugs produced without the supervision of the FDA. The group is also prioritizing rules that would notify patients when they are receiving compounded medicines that are exempt from FDA oversight.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA